DK141834B - Fremgangsmåde til fremstilling af en stabil suspension indeholdende sulfamethoxazol og trimethoprim. - Google Patents
Fremgangsmåde til fremstilling af en stabil suspension indeholdende sulfamethoxazol og trimethoprim. Download PDFInfo
- Publication number
- DK141834B DK141834B DK10478A DK10478A DK141834B DK 141834 B DK141834 B DK 141834B DK 10478 A DK10478 A DK 10478A DK 10478 A DK10478 A DK 10478A DK 141834 B DK141834 B DK 141834B
- Authority
- DK
- Denmark
- Prior art keywords
- trimethoprim
- sulfamethoxazole
- complex
- preparing
- suspension
- Prior art date
Links
- 239000000725 suspension Substances 0.000 title description 18
- WZRJTRPJURQBRM-UHFFFAOYSA-N 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 WZRJTRPJURQBRM-UHFFFAOYSA-N 0.000 title description 14
- 229940006995 sulfamethoxazole and trimethoprim Drugs 0.000 title description 6
- 238000004519 manufacturing process Methods 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 14
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 13
- 239000002245 particle Substances 0.000 description 12
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 11
- 229960001082 trimethoprim Drugs 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- 229960005404 sulfamethoxazole Drugs 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 239000013078 crystal Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 235000019658 bitter taste Nutrition 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229940047766 co-trimoxazole Drugs 0.000 description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 3
- 239000012429 reaction media Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 238000004452 microanalysis Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001938 Vegetable gum Polymers 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 235000019613 sensory perceptions of taste Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 230000035923 taste sensation Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK10478A DK141834B (da) | 1978-01-10 | 1978-01-10 | Fremgangsmåde til fremstilling af en stabil suspension indeholdende sulfamethoxazol og trimethoprim. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK10478 | 1978-01-10 | ||
| DK10478A DK141834B (da) | 1978-01-10 | 1978-01-10 | Fremgangsmåde til fremstilling af en stabil suspension indeholdende sulfamethoxazol og trimethoprim. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK10478A DK10478A (en, 2012) | 1979-07-11 |
| DK141834B true DK141834B (da) | 1980-06-30 |
| DK141834C DK141834C (en, 2012) | 1981-01-12 |
Family
ID=8089781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10478A DK141834B (da) | 1978-01-10 | 1978-01-10 | Fremgangsmåde til fremstilling af en stabil suspension indeholdende sulfamethoxazol og trimethoprim. |
Country Status (1)
| Country | Link |
|---|---|
| DK (1) | DK141834B (en, 2012) |
-
1978
- 1978-01-10 DK DK10478A patent/DK141834B/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK141834C (en, 2012) | 1981-01-12 |
| DK10478A (en, 2012) | 1979-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4145440A (en) | Liquid suspension of an aluminum salt of ibuprofen | |
| IE60759B1 (en) | Pharmaceutical formulations | |
| JPH0128757B2 (en, 2012) | ||
| JPS6191116A (ja) | 安定化された注射用ピロキシカム液剤 | |
| EP0340289A1 (en) | Liquid ibuprofen compositions and methods of making them | |
| IE45288B1 (en) | Improvements in or relating to pharmaceutical compostions for x-ray visualisation of the alimentary canal, and processes for preparing such compositions | |
| NZ211789A (en) | Pharmaceutical compositions containing an iron (iii) complex of a pyrone derivative, the compositions being adapted for buccal or nasal administration | |
| AU599034B2 (en) | Furosemide salts | |
| JP2735559B2 (ja) | 懸濁液 | |
| RU2676261C2 (ru) | Жидкие фармацевтические суспензии, содержащие висмут | |
| CA2001044C (en) | Oral liquid pharmaceutical compositions of sulindac | |
| CA1062721A (en) | Propionic acid derivatives | |
| JP2020516660A (ja) | 水酸化アルミニウムと水酸化マグネシウムを含む懸濁液及びその製造方法 | |
| FI78615C (fi) | Foerfarande foer framstaellning av ett komplex av karragenan och anvaendningen av karragenan som komplexbildande medel foer emepron. | |
| WO2003066022A2 (en) | Stable pharmaceutical composition useful for treating gastrointestinal disorders | |
| DK141834B (da) | Fremgangsmåde til fremstilling af en stabil suspension indeholdende sulfamethoxazol og trimethoprim. | |
| RU2118156C1 (ru) | Композиция - лекарственная форма противоартрозного средства глюкозамина гидрохлорида для инъекций | |
| Lehr | Prevention of Renal Damage by Mixtures of Sulphonamides | |
| JPH0296526A (ja) | 粉粒状医薬製剤 | |
| CN1128999A (zh) | 杂环化合物 | |
| US3142621A (en) | Alginate suspensions of oral pharmaceutical compositions with improved taste qualities | |
| JPH0665071A (ja) | 水性溶液製剤 | |
| RU2838731C1 (ru) | Гель димексида, обладающий противовоспалительным действием | |
| US2833690A (en) | Magnesium hydroxide suspensions containing sea-plant hydrocolloid | |
| US4377583A (en) | N-Methyl-D-glucamine salt of with 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-carboxylic acid |